These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 15469196)

  • 1. Thalamic dysfunction in schizophrenia: neurochemical, neuropathological, and in vivo imaging abnormalities.
    Clinton SM; Meador-Woodruff JH
    Schizophr Res; 2004 Aug; 69(2-3):237-53. PubMed ID: 15469196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thalamic pathology in schizophrenia.
    Cronenwett WJ; Csernansky J
    Curr Top Behav Neurosci; 2010; 4():509-28. PubMed ID: 21312411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutamatergic abnormalities of the thalamus in schizophrenia: a systematic review.
    Watis L; Chen SH; Chua HC; Chong SA; Sim K
    J Neural Transm (Vienna); 2008; 115(3):493-511. PubMed ID: 18301955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vesicular glutamate transporter transcript expression in the thalamus in schizophrenia.
    Smith RE; Haroutunian V; Davis KL; Meador-Woodruff JH
    Neuroreport; 2001 Sep; 12(13):2885-7. PubMed ID: 11588596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A post mortem study on neurochemical markers of dopaminergic, GABA-ergic and glutamatergic neurons in basal ganglia-thalamocortical circuits in Parkinson syndrome.
    Gerlach M; Gsell W; Kornhuber J; Jellinger K; Krieger V; Pantucek F; Vock R; Riederer P
    Brain Res; 1996 Nov; 741(1-2):142-52. PubMed ID: 9001716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testing models of thalamic dysfunction in schizophrenia using neuroimaging.
    Sim K; Cullen T; Ongur D; Heckers S
    J Neural Transm (Vienna); 2006 Jul; 113(7):907-28. PubMed ID: 16252070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implications for altered glutamate and GABA metabolism in the dorsolateral prefrontal cortex of aged schizophrenic patients.
    Gluck MR; Thomas RG; Davis KL; Haroutunian V
    Am J Psychiatry; 2002 Jul; 159(7):1165-73. PubMed ID: 12091195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Startle and sensorimotor correlates of ventral thalamic dopamine and GABA in rodents.
    Young KA; Randall PK; Wilcox RE
    Neuroreport; 1995 Dec; 6(18):2495-9. PubMed ID: 8741749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychotogenic drugs and delirium pathogenesis: the central role of the thalamus.
    Gaudreau JD; Gagnon P
    Med Hypotheses; 2005; 64(3):471-5. PubMed ID: 15617851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanisms underlying glutamatergic dysfunction in schizophrenia: therapeutic implications.
    Gaspar PA; Bustamante ML; Silva H; Aboitiz F
    J Neurochem; 2009 Nov; 111(4):891-900. PubMed ID: 19686383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of excitatory amino acid transporter interacting protein transcripts in the thalamus in schizophrenia.
    Huerta I; McCullumsmith RE; Haroutunian V; Giménez-Amaya JM; Meador-Woodruff JH
    Synapse; 2006 Jun; 59(7):394-402. PubMed ID: 16485262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Schizophrenia and glutamatergic transmission.
    Tamminga CA
    Crit Rev Neurobiol; 1998; 12(1-2):21-36. PubMed ID: 9444480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Up-regulation of NMDA receptor subunit and post-synaptic density protein expression in the thalamus of elderly patients with schizophrenia.
    Clinton SM; Haroutunian V; Meador-Woodruff JH
    J Neurochem; 2006 Aug; 98(4):1114-25. PubMed ID: 16762023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Schizophrenia; from structure to function with special focus on the mediodorsal thalamic prefrontal loop.
    Pakkenberg B; Scheel-Krüger J; Kristiansen LV
    Acta Psychiatr Scand; 2009 Nov; 120(5):345-54. PubMed ID: 19807715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The thalamus and schizophrenia: current status of research.
    Byne W; Hazlett EA; Buchsbaum MS; Kemether E
    Acta Neuropathol; 2009 Apr; 117(4):347-68. PubMed ID: 18604544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the thalamus in schizophrenia from a neuroimaging perspective.
    Pergola G; Selvaggi P; Trizio S; Bertolino A; Blasi G
    Neurosci Biobehav Rev; 2015 Jul; 54():57-75. PubMed ID: 25616183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopaminergic abnormalities in select thalamic nuclei in schizophrenia: involvement of the intracellular signal integrating proteins calcyon and spinophilin.
    Clinton SM; Ibrahim HM; Frey KA; Davis KL; Haroutunian V; Meador-Woodruff JH
    Am J Psychiatry; 2005 Oct; 162(10):1859-71. PubMed ID: 16199832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thalamic neurochemical abnormalities in individuals with prodromal symptoms of schizophrenia - relationship to auditory event-related potentials.
    Stone JM; Bramon E; Pauls A; Sumich A; McGuire PK
    Psychiatry Res; 2010 Aug; 183(2):174-6. PubMed ID: 20620033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions.
    Javitt DC
    Int Rev Neurobiol; 2007; 78():69-108. PubMed ID: 17349858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurobiological evidence for thalamic, hippocampal and related glutamatergic abnormalities in bipolar disorder: a review and synthesis.
    Ng WX; Lau IY; Graham S; Sim K
    Neurosci Biobehav Rev; 2009 Mar; 33(3):336-54. PubMed ID: 18955079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.